Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.1000
-0.0040 (-3.85%)
Feb 27, 2026, 2:56 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 127.67 million as of February 27, 2026. Its market cap has decreased by -30.90% in one year.
Market Cap
127.67M
Enterprise Value
145.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 127.67M, a decrease of -83.36%. That is a compound annual growth rate of -45.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 120.30M | 4.93% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.12T |
| Genmab | 112.81B |
| Coloplast | 110.06B |
| ALK-Abelló | 47.24B |
| BioPorto | 474.80M |
| ViroGates | 112.31M |
| Scandinavian Medical Solutions | 105.11M |
| Stenocare | 61.77M |